Patients with a history of retinopathy should undergo ophthalmologic evaluation before initiating therapy and be monitored during treatment, as determined by the prescribing provider
Tirzepatide and metformin effects on hunger and BMI in an adolescent with hyperphagia and severe obesity due to MC4R Deficiency: a case report
Other people say they have seen a decrease in their sexual desire while on GLP-1 medications, which may be connected to how these drugs interact with their brain's reward system
Sources Eli Lilly and Company: Tirzepatide for the Treatment of Obesity The New England Journal of Medicine: Tirzepatide Once Weekly for the Treatment of Obesity Diabetes Care: Efficacy and Safety of Tirzepatide for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis American Diabetes Association: Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes Obesity (Silver Spring): Predictors of Weight Loss Response with Once-Weekly Semaglutide Treatment NPR: Report on Compounded Tirzepatide and Legal Issues Important Medical Information and Disclaimers Important Current Status Update : On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide
The dosing protocol involves a gradual titration over several months, starting low to minimize gastrointestinal side effects and increasing to the target maintenance dose
According to clinical research, there are two primary mechanisms by which tirzepatide causes nausea: The slow digestion effect means food remains in your stomach longer than usual, creating a sensation of fullness and triggering nausea
)
